Clinical Trial Update: Study of Dextromethorphan in OCD and Related Disorders [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating dextromethorphan for obsessive-compulsive disorder and related disorders; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Body Dysmorphic Disorder
• Illness Anxiety Disorder
• Obsessive-compulsive Disorder
• Somatic Symptom Disorder

Drugs mentioned

• Dextromethorphan (dextromethorphan)

Snippet

Sponsor: Stanford University | Conditions: Obsessive-Compulsive Disorder, Illness Anxiety Disorder | Phase 2 | Status: RECRUITING